TABLE 3.
Treatment group |
P-values (F-test) |
|||||
Parameter | DA | DG | K | Treatment | Sex | Treatment × sex |
Cortisol (ng/ml) | ||||||
PND 5 | 33.53 ± 3.21 | 33.34 ± 3.22 | 26.46 ± 3.15 | 0.234 | 0.725 | 0.155 |
PND 16 | 22.78 ± 3.04 | 23.09 ± 3.08 | 17.29 ± 3.01 | 0.360 | 0.084 | 0.265 |
IgA (ng/ml) | ||||||
PND 5 | 2.23 ± 0.32 | 2.07 ± 0.32 | 2.02 ± 0.32 | 0.637 | 0.695 | 0.881 |
PND 16 | 0.12 ± 0.02 | 0.10 ± 0.02 | 0.10 ± 0.02 | 0.229 | 0.226 | 0.451 |
N/L ratio | ||||||
PND 5 | 2.05 ± 0.18 | 1.97 ± 0.18 | 2.11 ± 0.18 | 0.835 | 0.900 | 0.925 |
PND 16 | 0.82 ± 0.24 | 0.79 ± 0.24 | 0.99 ± 0.24 | 0.818 | 0.764 | 0.147 |
Results are presented as LSM ± SE of the three treatment groups DA (deprivation alone), DG (deprivation in a group with littermates), C (controls, no deprivation), and the p-values of the F-test. n = 50–55 per treatment group for cortisol and IgA; n = 40 per treatment group for neutrophil to lymphocyte (N/L) ratio.